- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 233/64 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
Patent holdings for IPC class C07D 233/64
Total number of patents in this class: 1272
10-year publication summary
|
116
|
109
|
97
|
90
|
91
|
85
|
76
|
82
|
95
|
54
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| King Faisal University | 914 |
37 |
| Allergan, Inc. | 2349 |
29 |
| Nippon Soda Co., Ltd. | 895 |
24 |
| Janssen Pharmaceutica N.V. | 3392 |
15 |
| Bristol-myers Squibb Company | 4898 |
13 |
| Bayer Pharma AG | 1052 |
13 |
| Centre National de La Recherche Scientifique | 10418 |
12 |
| ThermoLife International, LLC | 126 |
12 |
| F. Hoffmann-La Roche AG | 7925 |
11 |
| Allergan Holdings Unlimited Company | 40 |
11 |
| Daiichi Sankyo Company, Limited | 1869 |
11 |
| Takeda Pharmaceutical Company Limited | 2713 |
10 |
| Exelixis, Inc. | 399 |
10 |
| Lexicon Pharmaceuticals, Inc. | 205 |
9 |
| Translate bio, Inc. | 415 |
9 |
| Abbvie Inc. | 1800 |
8 |
| The Rockefeller University | 571 |
8 |
| The Salk Institute for Biological Studies | 445 |
8 |
| Merck Sharp & Dohme LLC | 3748 |
8 |
| Hoffmann-La Roche Inc. | 3418 |
7 |
| Other owners | 1007 |